In NASH patient liver biopsies, similar gene expression signatures were observed for ACACB/ACC2, DGAT1, THRB (downregulated) and CCR5, FGF21, LGALS3/MAC-2, SERPINH1/HSP47 (upregulated). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatohepatitis.